SCLN 8.58 Sciclone Pharmaceuticals $SCLN Hit a 52
Post# of 43
Posted On: 11/14/2014 2:48:03 PM
SCLN 8.58 Sciclone Pharmaceuticals $SCLN Hit a 52 week high of 8.68 Closing the day 09:44 at 8.58 -0.08 -0.92% With a day low of 8.53 and a total volume of 28,771.
SCLN Recent Posts: http://investorshangout.com/Sciclone-Pharmace...CLN-55380/
SCLN Sciclone Pharmaceuticals Recent Headline News
SciClone reports lower Q3 2014 GAAP net income of USD7.9m
M2 - Wed Nov 12, 7:18AM CST
Pharmaceutical company SciClone Pharmaceuticals (NasdaqGS:SCLN) disclosed on Tuesday its GAAP net income of USD7.9m (USD0.16 & USD0.15 per share, basic and diluted, respectively) for the Q3 2014.
SCLN: 8.47 (-0.19)
SciClone Pharma ups earnings guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:47AM CST
SCLN: 8.47 (-0.19)
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 8:47PM CST
SCLN: 8.47 (-0.19)
SciClone Pharmaceuticals (SCLN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
SCLN: 8.47 (-0.19)
SciClone Pharmaceuticals beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:16PM CST
SCLN: 8.47 (-0.19)
SciClone Reports Financial Results for the Third Quarter 2014
Marketwired - Mon Nov 10, 3:06PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the third quarter 2014.
SCLN: 8.47 (-0.19)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST
HK: 3.16 (+0.12), WWD: 51.03 (+0.90), LLNW: 2.68 (-0.01), FXEN: 2.71 (+0.13), RMTI: 10.65 (-0.36), CZR: 16.84 (+0.33), EGY: 7.14 (+0.13), ICUI: 85.67 (+0.72), ICEL: 7.60 (-0.04), SAAS: 8.82 (+0.01), DMD: 5.56 (+0.22), NPSP: 28.90 (-0.88), SCLN: 8.47 (-0.19), ATHX: 1.37 (-0.02), CMLS: 3.63 (+0.30), TC: 2.06 (+0.13), ATW: 35.65 (+0.53), CLUB: 5.62 (-0.16), RAX: 43.71 (+0.38), PTLA: 26.57 (-0.10), IPAR: 27.73 (-0.49), ATLS: 36.02 (-0.16), AMBC: 26.45 (+0.23), CUI: 7.09 (+0.03), PDLI: 7.75 (-0.14), OMER: 19.10 (-0.47), PRAA: 59.98 (-2.12), CARA: 8.11 (+0.05), HALO: 8.43 (-0.31), MODN: 10.35 (+0.11), CALL: 8.73 (+0.39), ASEI: 45.71 (+1.40), HGR: 21.26 (+0.02), ERII: 4.65 (-0.04)
Sciclone Pharmaceuticals Has Returned 41.6% Since SmarTrend Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Nov 07, 10:59AM CST
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 3 months, Sciclone Pharmaceuticals has returned 41.62% as of today's recent price of $7.69.
SCLN: 8.47 (-0.19)
SciClone to Present at Jefferies Global Healthcare Conference on November 19th
Marketwired - Thu Nov 06, 5:00AM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the Jefferies Global Healthcare Conference on November 19, 2014, at 4:20 pm GMT, taking place at the Waldorf Hilton Hotel in London, England.
SCLN: 8.47 (-0.19)
SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th
Marketwired - Thu Oct 30, 5:01AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2014 on Monday, November 10, 2014. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call will be hosted by Friedhelm Blobel, Ph.D., President and CEO, and Wilson W. Cheung, Senior Vice President and CFO.
SCLN: 8.47 (-0.19)
Sciclone Pharmaceuticals Shares Up 44.4% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Oct 24, 9:09AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 44.38% as of today's recent price of $7.84.
SCLN: 8.47 (-0.19)
3 Biotech Stocks Near 52-Week Highs Worth Selling
Motley Fool Staff - Motley Fool - Wed Oct 22, 12:01PM CDT
With markets dropping-and-popping this month investors are right to wonder whether rising volatility means that it's a good time to be moving out of high flying stocks. But just because a stock is hitting new highs doesn't mean that it isn't a great...
MACK: 8.41 (+0.02), BCRX: 9.99 (-0.40), BAX: 71.75 (-0.33), SCLN: 8.47 (-0.19), GSK: 45.76 (+0.10), CELG: 103.36 (-4.07)
Sciclone Pharmaceuticals Shares Up 26.7% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Thu Oct 09, 11:01AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 26.70% as of today's recent price of $6.88.
SCLN: 8.47 (-0.19)
Uptrend Call Working As Sciclone Pharmaceuticals Stock Rises 27.3% (SCLN)
Comtex SmarTrend(R) - Thu Oct 02, 9:42AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 27.26% as of today's recent price of $6.91.
SCLN: 8.47 (-0.19)
SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014
Marketwire - Wed Sep 17, 5:00AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at the 2014 BioCentury NewsMakers in the Biotech Industry conference at 11:30 am ET on Friday, September 26, 2014, at the Millennium Broadway Hotel & Conference Center in New York City.
SCLN: 8.47 (-0.19)
30.2% Return Seen to Date on SmarTrend Sciclone Pharmaceuticals Call (SCLN)
Comtex SmarTrend(R) - Wed Sep 10, 11:02AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 4 weeks, Sciclone Pharmaceuticals has returned 30.20% as of today's recent price of $7.07.
SCLN: 8.47 (-0.19)
SCLN Recent Posts: http://investorshangout.com/Sciclone-Pharmace...CLN-55380/
SCLN Sciclone Pharmaceuticals Recent Headline News
SciClone reports lower Q3 2014 GAAP net income of USD7.9m
M2 - Wed Nov 12, 7:18AM CST
Pharmaceutical company SciClone Pharmaceuticals (NasdaqGS:SCLN) disclosed on Tuesday its GAAP net income of USD7.9m (USD0.16 & USD0.15 per share, basic and diluted, respectively) for the Q3 2014.
SCLN: 8.47 (-0.19)
SciClone Pharma ups earnings guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:47AM CST
SCLN: 8.47 (-0.19)
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 8:47PM CST
SCLN: 8.47 (-0.19)
SciClone Pharmaceuticals (SCLN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
SCLN: 8.47 (-0.19)
SciClone Pharmaceuticals beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:16PM CST
SCLN: 8.47 (-0.19)
SciClone Reports Financial Results for the Third Quarter 2014
Marketwired - Mon Nov 10, 3:06PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the third quarter 2014.
SCLN: 8.47 (-0.19)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST
HK: 3.16 (+0.12), WWD: 51.03 (+0.90), LLNW: 2.68 (-0.01), FXEN: 2.71 (+0.13), RMTI: 10.65 (-0.36), CZR: 16.84 (+0.33), EGY: 7.14 (+0.13), ICUI: 85.67 (+0.72), ICEL: 7.60 (-0.04), SAAS: 8.82 (+0.01), DMD: 5.56 (+0.22), NPSP: 28.90 (-0.88), SCLN: 8.47 (-0.19), ATHX: 1.37 (-0.02), CMLS: 3.63 (+0.30), TC: 2.06 (+0.13), ATW: 35.65 (+0.53), CLUB: 5.62 (-0.16), RAX: 43.71 (+0.38), PTLA: 26.57 (-0.10), IPAR: 27.73 (-0.49), ATLS: 36.02 (-0.16), AMBC: 26.45 (+0.23), CUI: 7.09 (+0.03), PDLI: 7.75 (-0.14), OMER: 19.10 (-0.47), PRAA: 59.98 (-2.12), CARA: 8.11 (+0.05), HALO: 8.43 (-0.31), MODN: 10.35 (+0.11), CALL: 8.73 (+0.39), ASEI: 45.71 (+1.40), HGR: 21.26 (+0.02), ERII: 4.65 (-0.04)
Sciclone Pharmaceuticals Has Returned 41.6% Since SmarTrend Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Nov 07, 10:59AM CST
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 3 months, Sciclone Pharmaceuticals has returned 41.62% as of today's recent price of $7.69.
SCLN: 8.47 (-0.19)
SciClone to Present at Jefferies Global Healthcare Conference on November 19th
Marketwired - Thu Nov 06, 5:00AM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the Jefferies Global Healthcare Conference on November 19, 2014, at 4:20 pm GMT, taking place at the Waldorf Hilton Hotel in London, England.
SCLN: 8.47 (-0.19)
SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th
Marketwired - Thu Oct 30, 5:01AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2014 on Monday, November 10, 2014. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call will be hosted by Friedhelm Blobel, Ph.D., President and CEO, and Wilson W. Cheung, Senior Vice President and CFO.
SCLN: 8.47 (-0.19)
Sciclone Pharmaceuticals Shares Up 44.4% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Oct 24, 9:09AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 44.38% as of today's recent price of $7.84.
SCLN: 8.47 (-0.19)
3 Biotech Stocks Near 52-Week Highs Worth Selling
Motley Fool Staff - Motley Fool - Wed Oct 22, 12:01PM CDT
With markets dropping-and-popping this month investors are right to wonder whether rising volatility means that it's a good time to be moving out of high flying stocks. But just because a stock is hitting new highs doesn't mean that it isn't a great...
MACK: 8.41 (+0.02), BCRX: 9.99 (-0.40), BAX: 71.75 (-0.33), SCLN: 8.47 (-0.19), GSK: 45.76 (+0.10), CELG: 103.36 (-4.07)
Sciclone Pharmaceuticals Shares Up 26.7% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Thu Oct 09, 11:01AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 26.70% as of today's recent price of $6.88.
SCLN: 8.47 (-0.19)
Uptrend Call Working As Sciclone Pharmaceuticals Stock Rises 27.3% (SCLN)
Comtex SmarTrend(R) - Thu Oct 02, 9:42AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 27.26% as of today's recent price of $6.91.
SCLN: 8.47 (-0.19)
SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014
Marketwire - Wed Sep 17, 5:00AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at the 2014 BioCentury NewsMakers in the Biotech Industry conference at 11:30 am ET on Friday, September 26, 2014, at the Millennium Broadway Hotel & Conference Center in New York City.
SCLN: 8.47 (-0.19)
30.2% Return Seen to Date on SmarTrend Sciclone Pharmaceuticals Call (SCLN)
Comtex SmarTrend(R) - Wed Sep 10, 11:02AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 4 weeks, Sciclone Pharmaceuticals has returned 30.20% as of today's recent price of $7.07.
SCLN: 8.47 (-0.19)
(0)
(0)